PRKN and Parkinson disease: Despite LBs being reportedly absent in some PINK1 or PRKN mutant PD cases, the high abundance of pS65-Ub in non-mutation carriers suggests that the PINK1–PRKN pathway remains active in LBD and even has a complex, disease-context-dependent interaction with LB pathology.